Bulgarian Pharmaceuticals & Biotech Potentially Undervalued Companies

Aurora Cannabis

Market Cap: €334.6m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

Johnson & Johnson

Market Cap: €526.8b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

Bayer

Market Cap: €40.8b

Operates as a life science company worldwide.

Sanofi

Market Cap: €97.7b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Novo Nordisk

Market Cap: €1.7t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

Merck KGaA

Market Cap: €48.4b

Operates as a science and technology company in Germany and internationally.

Valneva

Market Cap: €403.7m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

Pfizer

Market Cap: €145.8b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Novavax

Market Cap: €1.3b

A biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally.

Evotec

Market Cap: €1.1b

Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.

Merck

Market Cap: €270.1b

Operates as a healthcare company worldwide.

Teva Pharmaceutical Industries

Market Cap: €36.4b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.